Indeed, M2‐like TAMs contribute to a tumor‐promoting microenvironment by secreting anti‐inflammatory cytokines such as IL‐10 and TGF‐β, which can dampen the activity of TRM cells and hinder their ability to control tumor progression. The gene discussed is IL10; the disease is neoplasm.